A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer Interventions: Drug: Paclitaxel; Drug: Bevacizumab; Drug: Carboplatin; Drug: Placebo Sponsor: Hoffmann-La Roche Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | China Health | Epithelial Cancer | Fallopian Tube Cancer | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | Study | Women